NDC 43742-2062 – Vir Combination

Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated) 12 [hp_X]/mL; Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2)… · Liquid · Oral

Human Otc Drug

Product NDC43742-2062

Product details

Brand name
Vir Combination
Generic name
Influenzinum (2022-2023), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Labeler
Deseret Biologicals, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
December 5, 2022
Marketing end
November 17, 2028
Pharmacologic class
Live Human Adenovirus Type 4 Vaccine; Live Human Adenovirus Type 7 Vaccine

Active ingredients

Uses, dosage, side effects and warnings for VIR Combination →

Package NDC codes (1)

Package NDCDescriptionSince
43742-2062-130 mL in 1 BOTTLE, DROPPER (43742-2062-1)Dec 5, 2022

Other VIR Combination products